Entries by Akesogen Admin

2014 BioGENEius Winner Kayla Evans Visits AKESOgen

February, 11, 2015 – The 2014 Georgia BioGENEius Winner, Kayla Evans visited Georgia Bio AKESOgen. The visit began with an introduction of the company and then the small group including Ms. Evans and her parents, and Georgia BioEd Institute Program Director, Melissa Nikolic, proceeded to tour the facility. Ms. Evans learned about opportunities in the life sciences […]

Share this FacebooktwitterredditlinkedinmailFacebooktwitterredditlinkedinmail

AKESOgen at the American Society of Human Genetics

AKESOgen scientists attended the American Society of Human Genetics meeting in San Diego October 18th-22nd 2014. Please email info@akesogen.com or call +1(770)542-0890 if you would like to follow up with delegate from the meeting. Share this

Share this FacebooktwitterredditlinkedinmailFacebooktwitterredditlinkedinmail

AKESOgen receives State of California Licensure to offer Clinical Testing

Atlanta, GA – 2nd October, 2014— Personalized medicine and genomics company AKESOgen today announced that its CLIA-compliant laboratory has received the California Clinical Laboratory License, which will allow the company to perform its oncology testing services on patient samples from the state of California. The Georgia based company said in a statement that it believes […]

Share this FacebooktwitterredditlinkedinmailFacebooktwitterredditlinkedinmail

AKESOgen launches Clinical Oncology Molecular Cytogenomics Microarray Test

Atlanta, GA – 1st April, 2014— Personalized medicine and genomics company AKESOgen today announced that its CLIA-compliant laboratory has launched a new clinically validated cytogenomics microarray test. The test measures Copy Number Alterations (CNAs) across the genome utilizing Illumina’s CytoSNP 850K beadarray. The assay is validated across a wide spectrum of cancers e.g. solid tumors […]

Share this FacebooktwitterredditlinkedinmailFacebooktwitterredditlinkedinmail